table of content
1 Introduction to Research & Analysis Reports
1.1 Monoclonal Antibody Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monoclonal Antibody Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monoclonal Antibody Therapy Overall Market Size
2.1 Global Monoclonal Antibody Therapy Market Size: 2022 VS 2029
2.2 Global Monoclonal Antibody Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monoclonal Antibody Therapy Players in Global Market
3.2 Top Global Monoclonal Antibody Therapy Companies Ranked by Revenue
3.3 Global Monoclonal Antibody Therapy Revenue by Companies
3.4 Top 3 and Top 5 Monoclonal Antibody Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Monoclonal Antibody Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monoclonal Antibody Therapy Players in Global Market
3.6.1 List of Global Tier 1 Monoclonal Antibody Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Monoclonal Antibody Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Monoclonal Antibody Therapy Market Size Markets, 2022 & 2029
4.1.2 Human Monoclonal Antibody
4.1.3 Humanized Monoclonal Antibody
4.1.4 Chimeric Monoclonal Antibody
4.1.5 Murine Monoclonal Antibody
4.2 By Type - Global Monoclonal Antibody Therapy Revenue & Forecasts
4.2.1 By Type - Global Monoclonal Antibody Therapy Revenue, 2018-2023
4.2.2 By Type - Global Monoclonal Antibody Therapy Revenue, 2024-2029
4.2.3 By Type - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Monoclonal Antibody Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Autoimmune Diseases
5.1.4 Others
5.2 By Application - Global Monoclonal Antibody Therapy Revenue & Forecasts
5.2.1 By Application - Global Monoclonal Antibody Therapy Revenue, 2018-2023
5.2.2 By Application - Global Monoclonal Antibody Therapy Revenue, 2024-2029
5.2.3 By Application - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Monoclonal Antibody Therapy Market Size, 2022 & 2029
6.2 By Region - Global Monoclonal Antibody Therapy Revenue & Forecasts
6.2.1 By Region - Global Monoclonal Antibody Therapy Revenue, 2018-2023
6.2.2 By Region - Global Monoclonal Antibody Therapy Revenue, 2024-2029
6.2.3 By Region - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Monoclonal Antibody Therapy Revenue, 2018-2029
6.3.2 US Monoclonal Antibody Therapy Market Size, 2018-2029
6.3.3 Canada Monoclonal Antibody Therapy Market Size, 2018-2029
6.3.4 Mexico Monoclonal Antibody Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Monoclonal Antibody Therapy Revenue, 2018-2029
6.4.2 Germany Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.3 France Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.4 U.K. Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.5 Italy Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.6 Russia Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.8 Benelux Monoclonal Antibody Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Monoclonal Antibody Therapy Revenue, 2018-2029
6.5.2 China Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.3 Japan Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.4 South Korea Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.6 India Monoclonal Antibody Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Monoclonal Antibody Therapy Revenue, 2018-2029
6.6.2 Brazil Monoclonal Antibody Therapy Market Size, 2018-2029
6.6.3 Argentina Monoclonal Antibody Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monoclonal Antibody Therapy Revenue, 2018-2029
6.7.2 Turkey Monoclonal Antibody Therapy Market Size, 2018-2029
6.7.3 Israel Monoclonal Antibody Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Monoclonal Antibody Therapy Market Size, 2018-2029
6.7.5 UAE Monoclonal Antibody Therapy Market Size, 2018-2029
7 Monoclonal Antibody Therapy Companies Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Monoclonal Antibody Therapy Major Product Offerings
7.1.4 Abbvie Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.1.5 Abbvie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Monoclonal Antibody Therapy Major Product Offerings
7.2.4 Amgen Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Glaxosmithkline
7.3.1 Glaxosmithkline Company Summary
7.3.2 Glaxosmithkline Business Overview
7.3.3 Glaxosmithkline Monoclonal Antibody Therapy Major Product Offerings
7.3.4 Glaxosmithkline Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.3.5 Glaxosmithkline Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Monoclonal Antibody Therapy Major Product Offerings
7.4.4 Merck Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Monoclonal Antibody Therapy Major Product Offerings
7.5.4 Novartis Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Monoclonal Antibody Therapy Major Product Offerings
7.6.4 Roche Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Johson & Johson
7.7.1 Johson & Johson Company Summary
7.7.2 Johson & Johson Business Overview
7.7.3 Johson & Johson Monoclonal Antibody Therapy Major Product Offerings
7.7.4 Johson & Johson Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.7.5 Johson & Johson Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Monoclonal Antibody Therapy Major Product Offerings
7.8.4 Novartis Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
